Webinar Includes : All the training handouts , certificate ,Q/A and 60 mins Live Webinar
Join us for a webinar on July 01 for a discussion of the webinar
The Coronaviruses (CoV) are positive sense RNA viruses possessing spike-like projections on the surface creating a crown-like appearance upon magnification with electron microscopy. They are a large family of viruses causing a wide range of illness from the common cold to more severe diseases, such as Middle East Respiratory Syndrome (MERS-CoV) and Severe Acute Respiratory Syndrome (SARS-CoV).
The novel coronavirus (2019-nCoV) or the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a man-made chimera that was engineered in 2015 in the University of North Carolina at Chapel Hill.
This engineered virus claimed its first victim in the Wuhan Institute of Virology, in Wuhan China in December 2019. On December 31st 2019, China notified the outbreak to the World Health Organization. The World Health Organization (WHO) on March 11, 2020, declared COVID-19 a pandemic, pointing to the over 118,000 cases of the coronavirus illness in over 110 countries and territories around the world and the sustained risk of further global spread.
We consider this epidemic a threat to the entire human life due to the lack of a sufficient preventive and treatment strategy to protect against it until now.
Why Should You Attend
There is a lot of information circulating online about COVID-19 and the drugs and vaccine candidates for it. There is a lot of confusion around what will happen to individuals, what this new enemy is that has suddenly appeared in our midst, interrupted/threatened our lives and what to do to stay safe.
The goal of this webinar it to provide clear information provide an update to the latest prevention and treatment strategies for COVID-19. The content is scientific in nature but simplified for people so that people without a strong scientific background can understand the content.
Webinar Takeaways
Epidemiology and pathogenesis
• Transmission
• Incubation period
• Prevention
• Risk factors
• Therapeutic recommendations
• Treatments:
- Antiviral drugs
- Broad spectrum antiviral drugs
- Systemic corticosteroid treatment
- Protease inhibitors
- Anti-iflammatories
- Antithrombotics/Anticoagolants
- Monoclonal antibodies
- Other proposed drugs for therapy
- Vaccine Candidates
- Natural Anti-Viral Agents
- Herbal Extracts
- Other Natural Sources
Learning Highlights
Following the completion of this webinar you will gain a basic to moderate knowledge of the prevention and treatment strategies available.
Countermeasures will be discussed at a high level and will be broken down into potential treatments that block the viral lifecycle (monoclonal antibodies, Camostat mesylate, chloroquine/hydroxychloroquine, lopinavir-ritonavir, remdesivir); potential anti-inflammatories (corticosteroids and baricitinib); immune boosters; and potential vaccines.
Can't Make this LIVE Webinar?
Simply select the On Demand option when registering and we will send you the link to view the recorded version.
Who will Benefit
- Anyone who has concerns about the COVID-19 pandemic and wants to understand more about the latest advances in prevention and treatment of COVID-19.
- Any industry or company of any size.
Industries who can attend
This 60 minute online course is intended for professionals in the Pharmaceutical and Biopharmaceutical Industry. Although not presently stated in the draft , the same guide could be used by FDA Regulated Industries personnel
Faculty Dr. Afsaneh Motamed Khorasani
Dr. Afsaneh Motamed Khorasani, PhD, is a Medical and scientific Affairs expert and a Senior Scientist with a strong background in biomedical science and clinical trial/research. She has a tenured and diverse range of experience in medical affairs, basic and industrial clinical research and development, clinical trials, Medical and regulatory writing and intellectual property. She is currently the Vice President of Medical Affairs at Easy Global Training, which is a US-based firm providing global regulatory, quality and medical affairs training backed by consulting.
